Fortress Biotech Inc (FBIO) — Cash Flow Quality Index
Latest as of September 2025:
-0.69x
Fortress Biotech Inc (FBIO) has a Cash Flow Quality Index of -0.69x as of September 2025. Operating cash flow of $-6.11 Million is below net income of $8.83 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Fortress Biotech Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.69x
Operating CF / Net Income
Operating Cash Flow
$-6.11 Million
USD
Net Income
$8.83 Million
USD
Data as of
Sep 2025
Most recent filing
Annual Cash Flow Quality Index for Fortress Biotech Inc (None–None)
Year-by-year earnings quality comparison for Fortress Biotech Inc. For live market cap and the full company financial profile, see FBIO market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.